Evolent Health (EVH) Income from Discontinued Operations (2020 - 2022)

Evolent Health has reported Income from Discontinued Operations for 3 years, with the latest figure at -$463000.0 in Q2 2022.

• On a quarterly basis, Income from Discontinued Operations changed N/A year-over-year to -$463000.0 in Q2 2022; TTM through Jun 2023 was -$463000.0, a 94.95% increase from a year earlier, with the FY2022 full-year figure at -$463000.0, up 93.67% from the prior year.
• Income from Discontinued Operations was -$463000.0 for Q2 2022 at Evolent Health, up from -$8.7 million in the prior quarter.
• The five-year high for Income from Discontinued Operations was $1.4 million in Q1 2021, with the low at -$8.7 million in Q4 2021.
• Average Income from Discontinued Operations over 3 years is -$2.0 million, with a median of -$1.1 million recorded in 2020.
• The largest YoY upside for Income from Discontinued Operations was 621.89% in 2021 against a maximum downside of 174.79% in 2021.
• Over 3 years, Income from Discontinued Operations stood at -$3.2 million in 2020, then sank by 174.79% to -$8.7 million in 2021, then soared by 94.68% to -$463000.0 in 2022.
• The last three Income from Discontinued Operations figures came in at -$463000.0 (Q2 2022), -$8.7 million (Q4 2021), and $1.4 million (Q1 2021), per Business Quant data.